Yahoo
NasdaqCM - Nasdaq Real Time Price USD

DiaMedica Therapeutics Inc. (DMAC)

9.25 -0.27 (-2.84%)
At close: October 30 at 4:00:01 PM EDT
9.25 -0.02 (-0.27%)
After hours: October 30 at 4:00:02 PM EDT
Trade DMAC on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
39,226
34,397
26,681
21,267
14,001
Operating Income
-39,226
-34,397
-26,681
-21,267
-14,001
Other Income Expense
1,715
1,659
2,267
1,929
353
Pretax Income
-37,511
-32,738
-24,414
-19,338
-13,648
Tax Provision
30
28
30
43
28
Net Income Common Stockholders
-37,541
-32,766
-24,444
-19,381
-13,676
Diluted NI Available to Com Stockholders
-37,541
-32,766
-24,444
-19,381
-13,676
Basic EPS
-0.72
-0.70
-0.60
-0.60
-0.52
Diluted EPS
-0.72
-0.70
-0.60
-0.60
-0.52
Basic Average Shares
52,452.32
46,980.78
40,404.68
32,566.72
26,443.07
Diluted Average Shares
52,452.32
46,980.78
40,404.68
32,566.72
26,443.07
Total Operating Income as Reported
-39,226
-34,397
-26,681
-21,267
-14,001
Total Expenses
39,226
34,397
26,681
21,267
14,001
Net Income from Continuing & Discontinued Operation
-37,541
-32,766
-24,444
-19,381
-13,676
Normalized Income
-37,541
-32,766
-24,444
-19,381
-13,676
EBIT
-39,226
-34,397
-26,681
-21,267
-14,001
EBITDA
-39,174
-34,354
-26,642
-21,237
-13,976
Reconciled Depreciation
52
43
39
30
25
Net Income from Continuing Operation Net Minority Interest
-37,541
-32,766
-24,444
-19,381
-13,676
Normalized EBITDA
-39,174
-34,354
-26,642
-21,237
-13,976
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 8/3/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: